Metabolic Disorder Drug May Improve Memory In Patients With Alzheimer's

by VR Sreeraman on  February 22, 2009 at 9:39 AM Drug News   - G J E 4
 Metabolic Disorder Drug May Improve Memory In Patients With Alzheimer's
A new study, conducted on mice, has shown that a drug used in a type of hereditary metabolic disorder could improve the memory of people suffering from Alzheimers disease.

Researchers of the Center for Applied Medical Research (CIMA) of the University of Navarra have shown that the drug sodium phenylbutyrate, prescribed until now for patients with alterations in the urea cycle, eases the fusion of proteins responsible for neuron connections, thus increasing the learning capacity of the mice involved.

According to researchers, these discoveries offer new, promising perspectives for the treatment of Alzheimers and other related dementias.

Dr. Ana Garcia-Osta, principal author of the study, said that these findings also provide a new alternative to the drugs that are currently available for fighting this devastating disease.

The research team is currently focused on discovering the acting mechanism in this drug.

As the drug is now clinically available and well tolerated, the confirmation of its therapeutic affectivity in humans could be applied to Alzheimers in a shorter period of time than other drugs being studied.

The study is published in the journal Neuropsychopharmacology.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like